These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 18571904

  • 1. Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis.
    Naber KG, Roscher K, Botto H, Schaefer V.
    Int J Antimicrob Agents; 2008 Aug; 32(2):145-53. PubMed ID: 18571904
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis.
    Paglia M, Peterson J, Fisher AC, Qin Z, Nicholson SC, Kahn JB.
    Curr Med Res Opin; 2010 Jun; 26(6):1433-41. PubMed ID: 20394471
    [Abstract] [Full Text] [Related]

  • 3. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
    Schaeffer AJ, Wu SC, Tennenberg AM, Kahn JB.
    J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
    [Abstract] [Full Text] [Related]

  • 4. [Practice management of chronic bacterial prostatitis with levofloxacin].
    Wagenlehner F, Roscher K, Naber KG.
    Aktuelle Urol; 2011 May; 42(3):184-9. PubMed ID: 21445824
    [Abstract] [Full Text] [Related]

  • 5. [Etiotropic therapy of chronic bacterial prostatitis].
    Popov SV, Mazo EB.
    Urologiia; 2008 May; (3):36, 38-41. PubMed ID: 18669346
    [Abstract] [Full Text] [Related]

  • 6. Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Sydnor TA, Kopp EJ, Anthony KE, LoCoco JM, Kim SS, Fowler CL.
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):357-62. PubMed ID: 9564988
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C, Jasovich A, Umeh O, Jiang J, Kaniga K, Friedland I.
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [Abstract] [Full Text] [Related]

  • 8. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
    Arguedas A, Dagan R, Pichichero M, Leibovitz E, Blumer J, McNeeley DF, Melkote R, Noel GJ.
    Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis.
    Nickel JC, Xiang J.
    J Urol; 2008 Apr; 179(4):1391-5. PubMed ID: 18289570
    [Abstract] [Full Text] [Related]

  • 10. Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study.
    Bundrick W, Heron SP, Ray P, Schiff WM, Tennenberg AM, Wiesinger BA, Wright PA, Wu SC, Zadeikis N, Kahn JB.
    Urology; 2003 Sep; 62(3):537-41. PubMed ID: 12946763
    [Abstract] [Full Text] [Related]

  • 11. [Laboratory and clinical study of ofloxacin in the treatment of bacterial prostatitis].
    Suzuki K, Tamai H, Naide Y, Ando K, Moriguchi R.
    Hinyokika Kiyo; 1984 Oct; 30(10):1505-18. PubMed ID: 6596877
    [Abstract] [Full Text] [Related]

  • 12. Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial.
    Giannarini G, Mogorovich A, Valent F, Morelli G, De Maria M, Manassero F, Barbone F, Selli C.
    J Chemother; 2007 Jun; 19(3):304-8. PubMed ID: 17594926
    [Abstract] [Full Text] [Related]

  • 13. Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval.
    Petitpretz P, Choné C, Trémolières F, Investigator Study Group.
    Int J Antimicrob Agents; 2007 Jul; 30(1):52-9. PubMed ID: 17512704
    [Abstract] [Full Text] [Related]

  • 14. Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients.
    Shorr AF, Khashab MM, Xiang JX, Tennenberg AM, Kahn JB.
    Respir Med; 2006 Dec; 100(12):2129-36. PubMed ID: 16730170
    [Abstract] [Full Text] [Related]

  • 15. Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.
    Tanaseanu C, Bergallo C, Teglia O, Jasovich A, Oliva ME, Dukart G, Dartois N, Cooper CA, Gandjini H, Mallick R, 308 Study Group, 313 Study Group.
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):329-38. PubMed ID: 18508226
    [Abstract] [Full Text] [Related]

  • 16. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J, Profant M, Kostrica R, Waskin H.
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [Abstract] [Full Text] [Related]

  • 17. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
    Peterson J, Kaul S, Khashab M, Fisher A, Kahn JB.
    Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
    [Abstract] [Full Text] [Related]

  • 18. Management of bacterial prostatitis: what's new?
    Naber KG.
    BJU Int; 2008 Mar; 101 Suppl 3():7-10. PubMed ID: 18307679
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis.
    Magri V, Trinchieri A, Pozzi G, Restelli A, Garlaschi MC, Torresani E, Zirpoli P, Marras E, Perletti G.
    Int J Antimicrob Agents; 2007 May; 29(5):549-56. PubMed ID: 17336504
    [Abstract] [Full Text] [Related]

  • 20. [Clinical studies of tosufloxacin on chronic bacterial prostatitis].
    Ikeuchi T, Kawamura N, Suzuki K, Onodera S, Osada T, Hirano A, Satomi Y, Yoshimura S, Yamamoto Y.
    Hinyokika Kiyo; 1993 Jul; 39(7):673-8. PubMed ID: 8362691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.